Evaluation of serum arabinitol as a diagnostic test for candidiasis

C. L. Wells, M. S. Sirany, D. J. Blazevic

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Gas-liquid chromatography was used to quantitate the arabinitol concentration on the sera of patients with candidiasis and in that of control patients. Serum arabinitol was elevated in 59% (n = 34) of patients with Candida sepsis, in 39% (n = 38) with Candida colonization, in 14% (n = 62) with bacterial sepsis, and in 0% (n = 11) of normal persons. The above patients were subsequently divided on the basis of renal function. Of those with decreases renal function, serum arabinitol was elevated in 89, 92, and 50% of patients with Candida sepsis, Candida colonization, and bacterial sepsis, respectively. Of those with normal renal function, serum arabinitol was elevated in only 23 and 14% of patients with Candida sepsis and Candida colonization, respectively. When serum arabinitol/creatinine ratios were calculated for patients with both increased arabinitol and increased creatinine, elevated ratios were obtained in 69, 36, and 0% of patients with Candida sepsis, Candida colonization, and bacterial sepsis, respectively.

Original languageEnglish (US)
Pages (from-to)353-357
Number of pages5
JournalJournal of clinical microbiology
Volume18
Issue number2
StatePublished - Jan 1 1983

Fingerprint

Dive into the research topics of 'Evaluation of serum arabinitol as a diagnostic test for candidiasis'. Together they form a unique fingerprint.

Cite this